88940-79-8Relevant academic research and scientific papers
Pyridoquinazolinecarboxamide Derivatives as Platelet Activating Factor Antagonists
Tilley, Jefferson W.,Burghardt, Barbara,Burghardt, Charles,Mowles, Thomas F.,Leinweber, Franz-Josef,et al.
, p. 466 - 472 (2007/10/02)
A series of N-pyridoquinazolines were evaluated for their ability to inhibit the binding of radiolabeled platelet activating factor (PAF) to its receptor on dog platelets.The most potent compounds in this series were found to be
Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
-
, (2008/06/13)
Pyrido[2,1-b]quinazoline derivatives of the formulas STR1 wherein R1, R2 and R3 are as hereinafter set forth, are described. The compounds of formulas I and II are useful as agents for the treatment of allergic conditions
